Evidence map›Paper›PMID 35888051›Full record

ReviewLife (Basel, Switzerland)2022

Strain Development in Microalgal Biotechnology-Random Mutagenesis Techniques.

Richard Bleisch, Leander Freitag, Yob Ihadjadene, Una Sprenger, Juliane Steingröwer, Thomas Walther, Felix Krujatz

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. HarvestingMarine drugs · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Richard BleischInstitute of Natural Materials Technology, Technische Universität Dresden, 01069 Dresden, Germany.
Leander FreitagInstitute of Natural Materials Technology, Technische Universität Dresden, 01069 Dresden, Germany.
Yob IhadjadeneInstitute of Natural Materials Technology, Technische Universität Dresden, 01069 Dresden, Germany.ORCID 0000-0002-6471-6177
Una SprengerInstitute of Natural Materials Technology, Technische Universität Dresden, 01069 Dresden, Germany.
Juliane SteingröwerInstitute of Natural Materials Technology, Technische Universität Dresden, 01069 Dresden, Germany.
Thomas WaltherInstitute of Natural Materials Technology, Technische Universität Dresden, 01069 Dresden, Germany.
Felix KrujatzInstitute of Natural Materials Technology, Technische Universität Dresden, 01069 Dresden, Germany.ORCID 0000-0001-7104-3591

Funding

Deutsche Forschungsgemeinschaft KR 5050/2-1European Commission 955520
6 · The paper itself

Abstract

Microalgal biomass and metabolites can be used as a renewable source of nutrition, pharmaceuticals and energy to maintain or improve the quality of human life. Microalgae's high volumetric productivity and low impact on the environment make them a promising raw material in terms of both ecology and economics. To optimize biotechnological processes with microalgae, improving the productivity and robustness of the cell factories is a major step towards economically viable bioprocesses. This review provides an overview of random mutagenesis techniques that are applied to microalgal cell factories, with a particular focus on physical and chemical mutagens, mutagenesis conditions and mutant characteristics.

Indexed as

algaemicroalgal biotechnologymutagensrandom mutagenesisstrain development

Identifiers

PMID35888051
PMCPMC9315690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.